Haemonetics
260 hedge funds and large institutions have $4.49B invested in Haemonetics in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 94 increasing their positions, 97 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% less funds holding
Funds holding: 279 → 260 (-19)
11% less capital invested
Capital invested by funds: $5.07B → $4.49B (-$581M)
30% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 54
Holders
260
Holding in Top 10
2
Calls
$3.55M
Puts
$962K
Top Buyers
| 1 | +$86.4M | |
| 2 | +$31.4M | |
| 3 | +$22.5M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$18.8M |
| 5 |
Neuberger Berman Group
New York
|
+$17.7M |
Top Sellers
| 1 | -$24.7M | |
| 2 | -$24.1M | |
| 3 | -$21.5M | |
| 4 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
-$20.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$17M |